Artos
PrivateLast Round
Seed
Mar 27, 2024
Total Funding Raised
$500,000
Momentum Score
50 /100
Company Overview
Artos is a technology company that has developed an AI-powered document authoring platform specifically for the life sciences industry. The platform is designed to help pharmaceutical and biotech companies draft regulatory and R&D documents—such as INDs, NDAs, and clinical study reports—more efficiently and accurately. By using agentic AI systems, automation, and traceability tools, Artos aims to reduce the time and cost associated with creating these complex submission documents, which are a critical step for getting products approved by regulatory bodies like the FDA. The system can synthesize data from various formats, generate high-quality first drafts in minutes, and ensure content is traceable and reproducible, addressing the stringent standards of the pharmaceutical sector. The company was part of Y Combinator's Winter 2024 batch.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Medical AI, Compliance, Document Management, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artos Comps
Public and private peers based on sector, stage, and business model.
Artos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 27, 2024 |
Artos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MyAsiaVC | Seed |
| Pioneer Fund | Seed |
| NVO Capital | Seed |
| Horizon | Seed |
| Maiora Ventures | Seed |
| Y Combinator | Seed |
| Phoenix Investment Club | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2024
$500K raised in Seed round.
Artos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Artos's valuation, stock price, and market status.
